Systemic Lupus Erythematosus (SLE) is a disease where the immune system attacks the body's own tissues, causing inflammation and pain. This study examines a new oral medicine called cenerimod to see if it can help reduce SLE symptoms in adults. The study will include 420 participants, with half receiving cenerimod and half receiving a placebo (a pill with no medicine) for 12 months. Researchers want to find out how well cenerimod works and if it's safe for people with SLE.
- Participants will either receive cenerimod or a placebo for 12 months.
- To join, you must already be on certain SLE medicines and meet health requirements.
- Women of childbearing age must agree to regular pregnancy tests and use effective birth control.
If you're interested, ensure that you meet the health requirements and are prepared for monthly check-ups and tests. This study aims to improve the treatment of SLE, and participation could contribute valuable information about managing this disease.
How understandable was the trial content above?
Hard to understand
Easy to understand